qXR-CTR vs VX1+
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is automated, rapid assessment of heart size and potential heart failure risk from standard chest X-ray images. This tool is ideal for radiologists and cardiologists seeking to streamline initial diagnostic screening and identify patients who may require further cardiac evaluation based on their cardiothoracic ratio.
View qXR-CTR →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time AI-driven insights to identify abnormal electrograms. This software is designed to enhance procedural efficiency and precision by assisting in the localization of target areas during complex interventional cardiology procedures.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | VX1+ |
|---|---|---|
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VX1+Tool B (VX1+) explicitly highlights a 'Simple user interface with color coding for electrogram dispersion,' indicating a direct and intuitive interaction for clinicians during procedures. While Tool A (qXR-CTR) offers automation, which enhances usability by reducing manual effort, its description does not detail the user interface itself, making Tool B's explicit UI description a stronger point for direct usability.
Clinical Value
VX1+Tool B (VX1+) provides real-time, AI-driven insights to assist electrophysiologists during complex cardiac ablation procedures for atrial fibrillation and tachycardia, directly impacting treatment during an intervention. Tool A (qXR-CTR) aids in the assessment of heart size and potential heart failure risk from X-rays, which is valuable for diagnosis and risk stratification. However, the real-time guidance during a critical interventional procedure offered by Tool B suggests a more immediate and direct impact on patient treatment outcomes.
Pricing & Value
TieBoth Tool A (qXR-CTR) and Tool B (VX1+) state that their pricing is not publicly disclosed and requires direct contact for details. Without transparent pricing information for either product, it is impossible to conduct a head-to-head comparison of their pricing or assess their relative value proposition.
Enterprise Readiness
qXR-CTRTool A (qXR-CTR) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, along with flexible deployment options (Cloud, on-premise, hybrid). While Tool B (VX1+) is expected to be HIPAA compliant and integrate with existing systems, these critical compliance aspects are not explicitly stated in its description. Tool A's clear declaration of compliance and deployment flexibility gives it an edge in general enterprise readiness.
Innovation
VX1+Tool B (VX1+) demonstrates a higher degree of innovation by applying AI in real-time during complex cardiac ablation procedures to identify spatio-temporal dispersed electrograms. This real-time, interventional guidance for a surgical procedure represents a more advanced and challenging application of AI compared to Tool A's automation of a standard cardiothoracic ratio measurement from X-ray images.
Support & Docs
TieNeither the provided structured facts nor publicly available web searches yielded specific details regarding the support offerings or documentation availability for either Tool A (qXR-CTR) or Tool B (VX1+). Without this information, it is not possible to differentiate between the two products on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | VX1+ |
|---|---|---|
| Name | qXR-CTR | VX1+ |
| Company | Qure.ai Technologies | Volta Medical |
| Description | qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Tagline | AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. | Transforming EP Data into AI Solutions |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Surgical AI |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and VX1+.